Cardiff Oncology Inc (CRDF) Live Share Price, Invest From India

Cardiff Oncology Inc Stock Performance

as on December 10, 2025 at 2:29 am IST

Day's Low
Day's High
$2.28
Day's Price Range
$2.49
$2.4
5.00%
Downside
3.75%
Upside
52 Week's Low
52 Week's High
$1.9
52-Week Price Range
$5.64
$2.4
20.83%
Downside
134.98%
Upside

Cardiff Oncology Inc share price movements today

Previous Close: $2.34
Open: $2.29
Volume: 2.9M
Day's Low - High: $2.28 - $2.49
52 Week Low - High: $1.9 - $5.64

Cardiff Oncology Inc Historical Returns

1 Month Return: + 6.85 %
3 Month Return: + 9.86 %
1 Year Return: -4.1 %
3 Year Return: + 63.64 %
5 Year Return: -87.98 %

Cardiff Oncology Inc Stock Fundamentals & Key Indicators

Check Cardiff Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$142.1M

EPS (TTM)

-0.7767

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-53.3M

Revenue (TTM)

501.0K

Profit Margin

0.00%

Return On Equity TTM

-102.71%

Cardiff Oncology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cardiff Oncology Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cardiff Oncology Inc	BUY	$142.1M	-87.98%	NA	0.00%
Insmed Incorporated	BUY	$41.9B	390.27%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	246.68%	1431.62	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$116.8B	97.01%	32.05	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$76.1B	43.92%	17.21	32.13%

Stock Returns calculator for Cardiff Oncology Inc Stock including INR - Dollar returns

The Cardiff Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cardiff Oncology Inc investment value today

Current value as on today

₹1,04,223

Returns

₹4,223

(+4.22%)

Returns from Cardiff Oncology Inc Stock

₹1,639 (-1.64%)

Dollar Returns*

₹5,862 (+5.86%)

Analyst Recommendation on Cardiff Oncology Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Cardiff Oncology Inc. Average target price of $9.93

Cardiff Oncology Inc Share Price Target

Get share price movements and forecasts by analysts on Cardiff Oncology Inc.

What analysts predicted

75.83%UPSIDE

Target Price

$9.93

Current Price

$2.4

Analyzed by

10 Analysts

Target

$9.93

Cardiff Oncology Inc target price $9.93, a slight upside of 75.83% compared to current price of $2.4. According to 10 analysts rating.

Cardiff Oncology Inc Stock’s Investor Sentiment and Interest

Search interest for Cardiff Oncology Inc Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 10, 2025 to December 10, 2025

Change:-28% versus previous 30 day period

Cardiff Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	-9	0	0	-11	0
Operating Income	-12	-10	-10	-10	-12	-12	-12	-14	-14	-11
EBITDA	-12	-10	-10	-10	-12	-12	-12	-14	-14	-10
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-9	-9	-10	-11	-11	-11	-13	-13	-11
Income Tax Expense	-1	-1	2	0	-	-	-	-	-	-
Net Income	-11	-9	-9	-10	-11	-11	-11	-13	-13	-11
Net Profit Margin	-10324.07%	-6901.42%	-5985.26%	-4883.41%	-7225.77%	-7184.85%	-7805.96%	-12324.77%	-11523.14%	-9381.67%

Cardiff Oncology Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	-1	-1	0	0	0	0	0	0	0
Operating Income	-25	-40	-25	-17	-16	-19	-28	-39	-45	-48
EBITDA	-24	-36	-22	-15	-15	-18	-28	-39	-45	-48
Interest Expense	1	1	1	0	0	0	0	1	-	-
Depreciation	-	-	1	0	0	0	0	0	0	0
Income Before Tax	-27	-39	-24	-16	-16	-19	-28	-38	-41	-45
Income Tax Expense	1	0	0	0	0	0	0	-1	0	0
Net Income	-27	-39	-24	-16	-16	-19	-28	-38	-41	-45
Net Profit Margin	-8776.68%	-10289.76%	-4932.08%	-4354.76%	-6709.74%	-5275.14%	-7880.50%	-10026.94%	-8492.01%	-6651.68%

Cardiff Oncology Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-9	-9	-10	-11	-11	-11	-13	-13	-11
Operating Cash Flow	-7	-7	-7	-9	-10	-10	-12	-8	-10
Investing Cash Flow	3	13	4	14	-9	4	-14	-4	10
Financing Cash Flow	0	0	0	2	7	44	0	-	0
Change in Cash	-4	6	-2	6	-12	38	-27	-13	0

Cardiff Oncology Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-39	-24	-16	-16	-19	-28	-38	-41	-45
Operating Cash Flow	-31	-23	-13	-13	-16	-23	-33	-30	-37
Investing Cash Flow	-24	23	0	0	0	-131	38	36	13
Financing Cash Flow	2	-6	16	12	137	35	0	-	53
Change in Cash	-53	-5	3	-1	120	-119	4	5	29

Global Institutional Holdings in Cardiff Oncology Inc

Funds	Holdings
BlackRock Inc	5.92%
Vanguard Group Inc	5.6%
Blair William & Co	3.79%
Pfizer Inc	3.62%
LAURION CAPITAL MANAGEMENT LP	2.7%

See all

Insights on Cardiff Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -13.94M → -11.25M (in $), with an average increase of 23.9% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, CRDF stock has moved up by 14.7%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 170.1% return, outperforming this stock by 174.2%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 964.7% return, outperforming this stock by 901.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 121.0K → 120.0K (in $), with an average decrease of 0.8% per quarter

About Cardiff Oncology Inc

trovagene is a precision medicine biotechnology company developing oncology therapeutics for improved cancer care by leveraging its proprietary precision cancer monitoring® (pcm) technology in tumor genomics. trovagene has broad intellectual property and proprietary technology to measure circulating tumor dna (ctdna) in urine and blood to identify and quantify clinically actionable markers for predicting response to cancer therapies. trovagene offers its pcm technology at its clia/cap – accredited laboratory and plans to continue to vertically integrate its pcm technology with precision cancer therapeutics. trovagene's lead therapeutic asset is pcm-075, an oral, investigational drug and a highly-selective polo-like kinase 1 (plk1) inhibitor for the treatment of acute myeloid leukemia (aml). among the four members of the plk family, plk1 is recognized to be the fundamental component for cell division to take place correctly. most importantly, plk1 is only expressed in dividing cells, wh

Organisation	Cardiff Oncology Inc
Headquarters	11055 Flintkote Avenue, San Diego, CA, United States, 92121
Industry	Health Services
CEO	Dr. Mark Erlander Ph.D.
E-voting on shares	Click here to vote

Key Management of Cardiff Oncology Inc

Name	Title
Ms. Brigitte Lindsay	Senior Vice President of Finance
Mr. Charles Monahan R.Ph.	Senior Vice President of Regulatory Affairs
Dr. Roger Sidhu M.D.	Chief Medical Officer
Dr. Mark Erlander Ph.D.	CEO & Director
Mr. James E. Levine	Chief Financial Officer
Dr. Tod Smeal Ph.D.	Chief Scientific Officer
Ms. Elizabeth Anderson	VP of Finance & Administration

FAQs

What is Cardiff Oncology Inc share price today?

Cardiff Oncology Inc share price today is $2.4 as on December 10, 2025 at 2:29 am IST at the close of the market. Cardiff Oncology Inc share today touched a day high of $2.49 and a low of $2.28.

What is the 52 week high and 52 week low for Cardiff Oncology Inc share?

Cardiff Oncology Inc share touched a 52 week high of $5.64 on December 17, 2024 and a 52 week low of $1.9 on November 21, 2025. Cardiff Oncology Inc stock price today i.e. December 10, 2025 at 2:29 am IST is closed at $2.4,which is 57.44% down from its 52 week high and 26.32% up from its 52 week low.

What is Cardiff Oncology Inc's market capitalisation today?

Cardiff Oncology Inc market capitalisation is $0.00T as on December 10, 2025 at 2:29 am IST.

How to invest in Cardiff Oncology Inc Stock (CRDF) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cardiff Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cardiff Oncology Inc Shares that will get you 0.6250 shares as per Cardiff Oncology Inc share price of $2.4 per share as on December 10, 2025 at 2:29 am IST.

What is the minimum amount required to buy Cardiff Oncology Inc Stock (CRDF) from India?

Indian investors can start investing in Cardiff Oncology Inc (CRDF) shares with as little as ₹89.831 or $1 (as of December 10, 2025 at 2:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹898.31 in Cardiff Oncology Inc stock (as per the Rupee-Dollar exchange rate as on December 10, 2025 at 2:37 am IST). Based on Cardiff Oncology Inc share’s latest price of $2.4 as on December 10, 2025 at 2:29 am IST, you will get 4.1667 shares of Cardiff Oncology Inc. Learn more about fractional shares .

What are the returns that Cardiff Oncology Inc has given to Indian investors in the last 5 years?

Cardiff Oncology Inc stock has given -87.98% share price returns and 22.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?